RPRX
RoyaltyDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
RPRX vs peer average
38/100
RPRX vs. peer average (D vs. C)
Grade spread
A 1 · B 2 · C 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
BIIB is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $36.06B
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RPRX
Royalty
BIIB
Biogen
Grade
D
C
Momentum
91
93
Value
62
64
Sentiment
31
40
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs BIIB
RPRX / BIIB
Grade Position
Below peers
RPRX vs. peer average (D vs. C)
38/100
Momentum
91
BIIBValue
62
BIIBSentiment
31
BIIBRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RPRX
BIIB is the first peer returned for this comparison set.